Skip to main content

Table 2 Severity of nausea

From: Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer

 

Control group (n = 52)

Aprepitant group (n = 54)

P-value

Grade 0

Grade 1

Grade 2

Grade 0

Grade 1

Grade 2

Acute phase

51

1

0

54

0

0

0.32

Delayed phase

39

9

4

40

8

6

0.85

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us